Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 08/26/20 → 03/11/23 |
Funding
- ICON Clinical Research: $12,408.00
Pfizer: A Phase 3, Randomized, Double-Blind Trial To Evaluate The Safety And Immunogenicity Of A 20-Valent Pneumococcal Conjugate Vaccine In Healthy Infants
- Beneri, Christy (PI)
- Handel, Andrew (CoPI)
- Nachman, Sharon (CoPI)
- Fisher, Matthew (CoPI)
- Hymes, Saul (CoPI)
Project: Research